Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28948577 | 0.82 | REV1 (0.40) | CES2CES1 | |
| SCHEMBL27630601 | 0.82 | GABRA1 (0.34) | MAPTGAANPC1KDM4EL3MBTL1 | |
| SCHEMBL30858726 | 0.82 | GABRA1 (0.34) | MAPTGAANPC1KDM4EL3MBTL1 | |
| SCHEMBL22604933 | 0.80 | MAPT (0.31) | MAPTGAANPC1MAPK1KDM4E | |
| SCHEMBL28459050 | 0.79 | REV1 (0.34) | GAA | |
| SCHEMBL15733288 | 0.76 | HTR3E (0.45) | MAPTNPC1L3MBTL1MEN1KMT2A | |
| SCHEMBL29365405 | 0.76 | HTR3E (0.45) | MAPTNPC1L3MBTL1MEN1KMT2A | |
| SCHEMBL23355905 | 0.75 | GABRA1 (0.41) | MAPK1L3MBTL1GABRA1GABRG2GABRB3 | |
| SCHEMBL28674655 | 0.74 | CA12 (0.38) | MAPTGAAMAPK1KDM4EMEN1 | |
| SCHEMBL14691418 | 0.74 | HTR3E (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113773204-B | Preparation method of fluoroaniline | 上海万溯药业有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-113773204-A | Preparation method of fluoroaniline | 上海万溯药业有限公司 | 2021-12-10 | — | — | CN | claimed |
| CN-107043335-A | A kind of preparation method of 2 fluorophenyl azido compound | 湖南华腾制药有限公司 | 2017-08-15 | — | — | CN | claimed |
| US-12612409-B2 | Pyrrolopyrimidines as CFTR potentiators | CYSTIC FIBROSIS FOUNDATION (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260033119-A1 | A PHOTONIC-ORGANIC ELECTROCHEMICAL TRANSISTOR | PURDUE RESEARCH FOUNDATION (US) | 2026-01-29 | — | — | US | disclosed |
| US-12473263-B2 | Bicyclic inhibitors of CBX chromodomains | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2025-11-18 | — | — | US | disclosed |
| US-12466811-B2 | Mass spectrometry cleavable heterobifunctional photoactivated cross-linkers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-11 | — | — | US | disclosed |
| WO-2025063899-A1 | A DYNAMIC CROSSLINKER, COVALENT ADAPTABLE NETWORK COMPRISING POLYMER NETWORK CROSSLINKED BY SAID DYNAMIC CROSSLINKER AND RELATED METHODS THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-03-27 | — | — | WO | disclosed |
| WO-2024187047-A1 | A PHOTONIC-ORGANIC ELECTROCHEMICAL TRANSISTOR | PURDUE RESEARCH FOUNDATION (US) | 2024-09-12 | — | — | WO | disclosed |
| EP-4424311-A2 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | Cystic Fibrosis Foundation (US) | 2024-09-04 | — | — | EP | disclosed |
| CN-118420815-A | Polybutadiene polymer containing fluorophenyl azide/perfluorophenyl, preparation method thereof and application thereof in flexible laminated solar cell | 江汉大学 | 2024-08-02 | — | — | CN | disclosed |
| US-20100168167-A1 | Piperidinones Useful in the Treatment of Inflammation | BIOLIPOX AB (SE) | 2010-07-01 | — | — | US | disclosed |
| US-20100137587-A1 | Heterocyclic compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2010-06-03 | — | — | US | disclosed |
| EP-2134686-A1 | PIPERIDINONES USEFUL IN THE TREATMENT OF INFLAMMATION | Biolipox AB (SE) | 2009-12-23 | — | — | EP | disclosed |
| WO-2009080663-A1 | TRIAZOLE OXADIAZOLES DERIVATIVES | MERCK SERONO S.A. (CH) | 2009-07-02 | — | — | WO | disclosed |
| WO-2008110793-A1 | PIPERIDINONES USEFUL IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2008-09-18 | — | — | WO | disclosed |
| US-20070191389-A1 | Biaryl derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| CN-1980901-A | Biaryl derivatives | BANYU PHARMA CO LTD (JP) | 2007-06-13 | — | — | CN | disclosed |
| EP-1764362-A1 | BIARYL DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-03-21 | — | — | EP | disclosed |
| CN-1934094-A | Diaryl substituted heterocyclic 5-membered ring derivatives | BANYU PHARMA CO LTD (JP) | 2007-03-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12473263-B2 | Bicyclic inhibitors of CBX chromodomains | CBX2, CBX3, CBX6 | MAPT 4531/4885GAA 4034/4885NPC1 2302/4885 |
| US-20260033119-A1 | A PHOTONIC-ORGANIC ELECTROCHEMICAL TRANSISTOR | PARN, PARL, KCNN4 | MAPT 752/4885GAA 4364/4885NPC1 4450/4885 |
| US-20100168167-A1 | Piperidinones Useful in the Treatment of Inflammation | ARG1, ARG2, PRMT1 | MAPT 3306/4885GAA 4214/4885NPC1 2774/4885 |
| US-12612409-B2 | Pyrrolopyrimidines as CFTR potentiators | CFTR, CLCN2, SLC26A3 | MAPT 4880/4885GAA 2850/4885NPC1 251/4885 |
| US-20070191389-A1 | Biaryl derivatives | GRM1, GRIN1, GRIN2B | MAPT 1892/4885GAA 2964/4885NPC1 1716/4885 |
| US-20100137587-A1 | Heterocyclic compound and use thereof | REN, AGT, ACE | MAPT 4513/4885GAA 825/4885NPC1 3316/4885 |
| US-12466811-B2 | Mass spectrometry cleavable heterobifunctional photoactivated cross-linkers | JMJD7, DCLRE1A, PTMS | MAPT 2399/4885GAA 3599/4885NPC1 4880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.